Showing 541 - 560 results of 66,559 for search '(( 50 ((we decrease) OR (((a decrease) OR (nn decrease)))) ) OR ( 2 d decrease ))', query time: 1.45s Refine Results
  1. 541
  2. 542
  3. 543
  4. 544
  5. 545

    (A) The proportion of fast MyHC myotubes is decreased in Igf-2 deficient mice (maternal disomy Chromosome 7 - MatDi) at E14 by Deborah Merrick (54928)

    Published 2011
    “…<p><b>Copyright information:</b></p><p>Taken from "A role for Insulin-like growth factor 2 in specification of the fast skeletal muscle fibre"</p><p>http://www.biomedcentral.com/1471-213X/7/65</p><p>BMC Developmental Biology 2007;7():65-65.…”
  6. 546
  7. 547
  8. 548
  9. 549

    Rac and PKB activities are required for a late phase of cerebellar LTP. by Claire Jackson (362873)

    Published 2010
    “…<p><b>A</b>) Addition of the Rac inhibitor EHT1864 (50 µM; n = 7) to pipette solution decreases LTP duration. …”
  10. 550

    <i>tho2</i> and <i>hpr1</i> selectively decrease the expression level of Rif1p. by Tai-Yuan Yu (328952)

    Published 2013
    “…(<b>D</b>) <i>tho2</i> and <i>hpr1</i> reduced the <i>RIF1</i> RNA levels. …”
  11. 551

    Inhibition of GLS1 decreases the proportion of CCR6 and CXCR3 expressing CD4<sup>+</sup> T cells. by Zeynep Sener (3146064)

    Published 2016
    “…(B–C) The proportion of CCR6 expressing cells at day 3 (left) and day 5 (right) under normoxia (black bars) and hypoxia (grey bars) in the presence (+) and absence (-) of 25 μM BPTES and 50 μM 968. BPTES and 968 significantly decrease the proportion of CCR6 expressing cells under normoxia both at day 3 and 5, whereas 968 but not BPTES decrease the proportion of CCR6 expressing cells under hypoxia both at day 3 and 5. …”
  12. 552
  13. 553
  14. 554
  15. 555

    Fenretinide decreases levels of PAX3/FOXO1 and its target genes in aRMS cell lines. by David Herrero Martín (286820)

    Published 2013
    “…D) Fenretinide did not decrease mRNA levels of FOXO1 in aRMS cells. qRT–PCR was carried out after treatment with an IC<sub>50</sub> concentration of fenretinide during different time points (24–48–72 hours). …”
  16. 556
  17. 557
  18. 558
  19. 559
  20. 560

    Decreased Platelet Count in Patients Receiving Continuous Veno-Venous Hemofiltration: A Single-Center Retrospective Study by Buyun Wu (563610)

    Published 2014
    “…<div><p>Background</p><p>A decreased platelet count may occur and portend a worse outcome in patients receiving continuous renal replacement therapy (CRRT). …”